TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive This month’s 8-page Business & Regulatory Report included in this issue. January 30, 2004
TCL Archive Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data November 22, 2013
TCL Archive NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups July 15, 1983
